We are excited to share that BioSpace has selected Light Horse Therapeutics as one of its 15 NextGen: Class of 2026 – top life sciences startups to watch this year. To come up with this list, BioSpace identified companies that announced initial, seed or series A rounds between October 1, 2024, and September 30, 2025. They were then assessed using several different criteria including finance, partnerships, pipeline, growth potential and innovation until the BioSpace editorial team came up with its top 15 picks.
https://www.biospace.com/nextgen
